Gene · 5921
NIH grants2,330
NIH grants whose papers are about the gene, through NIH's grant-paper links.
981 to 1,000 of 2,330
Download this page as JSON| Grant | Title | RASA1 papers | Newest fiscal year |
|---|---|---|---|
| R01CA168393 | SOX9 Mediation of AR and ERG Driven Prostate Cancer | 1 | 2018 |
| R01CA175360 | The role of deubiquitinating enzyme USP33 in Slit-Robo signaling in lung cancer | 1 | 2018 |
| R01CA175741 | Store-operated calcium entry in tumor invasion and metastasis | 1 | 2018 |
| R01CA176326 | Complex Role of HSF1 in Breast Cancer | 1 | 2018 |
| R01CA179363 | Molecular signature of inflammation | 1 | 2018 |
| R01CA182684 | Signal Integration of Transcriptional Pathways in Gliomagenesis | 1 | 2018 |
| R01CA182905 | Protein-coding and non-coding RNA biomarkers for early detection of CLL | 1 | 2018 |
| R01CA183459 | Targeting Mucin and EGFR Axis in Pancreatic Cancer | 1 | 2018 |
| R01CA194663 | (PQC1) Accelerated biological aging and colon polyp to cancer progression | 1 | 2018 |
| R01DA034116 | Synaptic actin dynamics and the selective vulnerability of drug-associated memory | 1 | 2018 |
| R01DC013668 | Improving clinical speech remediation with ultrasound technology | 1 | 2018 |
| R01DK087956 | Motor protein Myo1c participates in Nephrin and Neph1 signaling | 1 | 2018 |
| R01DK100081 | Hypoxia and inflammatory injury in human renovascular hypertension | 1 | 2018 |
| R01DK102487 | The role of hepatic Sortlin 1 in diabetic dyslipidemia | 1 | 2018 |
| R01ES012974 | Epigenetic Transgenerational Endocrine Disruptor Actions | 1 | 2018 |
| R01GM073960 | Computational Design of Protein-Protein Interactions | 1 | 2018 |
| R01GM075249 | Roles of Chromosomal Factors in Chromosome Segregation | 1 | 2018 |
| R01GM104184 | Predicting the Heterogeneity of Cell-Fate Decisions | 1 | 2018 |
| R01GM108014 | Novel Regulators of Wound Angiogenesis | 1 | 2018 |
| R01GM113166 | Polymeric Nanomedicines of Hedgehog Inhibitor and miRNA for Treating Pancreatic Cancer | 1 | 2018 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5921/grants?page=50